stoxline Quote Chart Rank Option Currency Glossary
Nuwellis, Inc. (NUWE)
0.5999  0.005 (0.82%)    12-07 16:00
Open: 0.6
High: 0.6
Volume: 55,325
Pre. Close: 0.595
Low: 0.5711
Market Cap: 2(M)
Technical analysis
2023-12-07 4:22:25 PM
Short term     
Mid term     
Targets 6-month :  0.88 1-year :  1.03
Resists First :  0.75 Second :  0.88
Pivot price 0.62
Supports First :  0.54 Second :  0.44
MAs MA(5) :  0.59 MA(20) :  0.61
MA(100) :  1.39 MA(250) :  3.9
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  12.1 D(3) :  11.3
RSI RSI(14): 38.4
52-week High :  16.54 Low :  0.54
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NUWE ] has closed above bottom band by 36.2%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.6 - 0.6 0.6 - 0.61
Low: 0.57 - 0.57 0.57 - 0.57
Close: 0.6 - 0.6 0.6 - 0.6
Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Headline News

Thu, 30 Nov 2023
Nuwellis Inc (NUWE) Stock Gains 6.45% This Week: Is It a Good Pick? - InvestorsObserver

Mon, 13 Nov 2023
Here's Why Nuwellis, Inc. (NUWE) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Wed, 08 Nov 2023
Nuwellis, Inc. (NASDAQ:NUWE) Q3 2023 Earnings Call Transcript - Yahoo Finance

Tue, 17 Oct 2023
Nuwellis Inc (NUWE) Stock Rises 0.97% This Week; Should You Buy? - InvestorsObserver

Mon, 16 Oct 2023
Should You Buy Nuwellis Inc (NUWE) Stock Monday Morning? - InvestorsObserver

Fri, 13 Oct 2023
Why Nuwellis (NUWE) Stock Is Nosediving - Nuwellis (NASDAQ:NUWE) - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 3 (M)
Shares Float 3 (M)
Held by Insiders 0.4 (%)
Held by Institutions 1 (%)
Shares Short 173 (K)
Shares Short P.Month 375 (K)
Stock Financials
EPS 26.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.19
Profit Margin -191.9 %
Operating Margin -131.2 %
Return on Assets (ttm) -78.2 %
Return on Equity (ttm) -151.9 %
Qtrly Rev. Growth 16.7 %
Gross Profit (p.s.) 1.45
Sales Per Share 2.65
EBITDA (p.s.) -5.63
Qtrly Earnings Growth 0 %
Operating Cash Flow -18 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio 0.02
PEG Ratio 0
Price to Book value 0.14
Price to Sales 0.22
Price to Cash Flow -0.11
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android